simvastatin has been researched along with Brain Emboli in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alcazar, A; Ayuso, MI; Campos-Martorell, M; Canals, F; Chacón, P; García-Bonilla, L; Hernández-Guillamon, M; Monge, M; Montaner, J; Rosell, A; Salvador, N | 1 |
Han, MK; Lapchak, PA | 1 |
Amin-Hanjani, S; Asahi, M; Huang, PL; Huang, Z; Liao, JK; Lo, EH; Mori, T; Moskowitz, MA; Qiu, J; Sumii, T; Thomas, S; Yoshimura, S | 1 |
Shabanzadeh, AP; Shuaib, A; Wang, CX | 1 |
4 other study(ies) available for simvastatin and Brain Emboli
Article | Year |
---|---|
Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model.
Topics: Animals; Blotting, Western; Brain; Brain Chemistry; Electrophoresis, Gel, Two-Dimensional; HSP90 Heat-Shock Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Neurologic Examination; Proteomics; Rats; Rats, Wistar; Simvastatin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stroke | 2014 |
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Male; Preoperative Care; Rabbits; Rats; Simvastatin; Thrombolytic Therapy; Tissue Plasminogen Activator | 2009 |
Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Topics: Animals; Atorvastatin; Brain Ischemia; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyrroles; Simvastatin; Stroke; Tissue Plasminogen Activator | 2005 |
Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Intracranial Embolism; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion; Simvastatin; Stroke; Treatment Outcome | 2005 |